Skip to main content
PPCB logo
PPCB
(NASDAQ)
Propanc Biopharma, Inc.
$0.07-- (--)
Loading... - Market loading

Propanc Biopharma (PPCB) Stock Price & Financial Analysis

Propanc Biopharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.86 - $2.07
52-Week High$10.81
52-Week Low$0.09
Open$1.98
Volume158.74K
Average Volume (3M)211.63K
Market Cap908.50K
Shares Outstanding13.36M
Price to Sales (P/S)30.38
Price to Book (P/B)0.09
EV/EBITDA-0.03
Revenue (TTM)29.90K
Net Income (TTM)-66.07M
Free Cash Flow (TTM)-3.11M
EPS (TTM)$-6.35
Profit Margin-220933.45%
Operating Margin-217704.18%
Return on Equity (ROE)-632.09%
Debt to Equity0.16
50-Day MA$0.12
200-Day MA$1.42
52-Week Change-96.58%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Propanc Biopharma

What is the current stock price for PPCB?

As of the latest trading session, PPCB stock trades at $2.00. The 52-week range is $0.09–$10.81, with a day range of $1.86–$2.07.

What is the P/E ratio for PPCB?

The P/E ratio (Price-to-Earnings) for PPCB is shown in the Key Statistics section. This valuation metric helps compare Propanc Biopharma, Inc. to industry peers.

Does PPCB pay dividends?

Propanc Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PPCB?

Analyst ratings and recommendations for PPCB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PPCB?

Propanc Biopharma's market capitalization is $26.8M, classifying it as a micro-cap company. Propanc Biopharma operates in the Healthcare sector within the Biotechnology industry.